AzTrials
AzTrials

FibromyalgiaNCT04220567

Effectiveness of Exercise and Patient-centred Education on Fibromyalgia

A study testing Experimental: Exercise and Patient-centred education and Active Comparator: Exercise in people with Fibromyalgia, run by Instituto Politécnico de Setúbal. Escola Superior de Saúde. at 1 site in Portugal.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to compare the effects of an eight-week exercise and patient-centred education programme with eight-week exercise alone programme on disability, pain intensity, health-related quality of life and patient global impression of change. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Fibromyalgia
What is being tested?
Experimental: Exercise and Patient-centred education and Active Comparator: Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 sitePortugal
Study dates
7 Jan 2020to Oct 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosis of fibromyalgia according to the American College of Rheumatology criteria (2016)

Who cannot join

  • Presence of uncontrolled medical disorders (cardiovascular/ metabolic/ neurological/ renal)
  • Presence of active oncological disease (or until 5 years and undergoing treatment)
  • Presence of inflammatory rheumatic diseases other than fibromyalgia
  • Presence of inflammatory osteoarticular disease or severe osteoarthritis (grade IV de Kellgren - Lawrence Classification of Osteoarthritis)
  • Previous orthopaedic (column or lower limb) or cardiothoracic surgery in the year before;
  • Disability not compatible with the exercise practice required
Show all 9Show fewer
  • Pregnancy
  • Attendance to a physiotherapy programme including exercise in the previous three months
  • Difficulty in written communication that prevent the fulfilment of self-reported questionnaires.

Trial locations and contacts

1 site in 1 country.

Portugal1 site, 1 recruiting
  • Carmen Caeiro

    Setúbal, 2914-503

    Carmen Caeiro, PhD, 00351 265 709 382 ext. 5382, carmen.caeiro@ess.ips.pt

    Patrícia Falcão, BSc Hons, 00351 265 709 382 ext. 5382, patricia.falcao@ess.ips.pt

    Recruiting

Other trials in Portugal

About this study

Official title: Is a Combined Programme of Exercise and Patient-centred Education More Effective Than Exercise Alone in Individuals With Fibromyalgia? A Randomised Controlled Trial

This study aims to compare the effects of an eight-week exercise and patient-centred education programme with eight-week exercise alone programme on disability, pain intensity, health-related quality of life and patient global impression of change.

A prospective, parallel, double-blinded and multi-centre randomised controlled trial will be carried out.

Conditions
Fibromyalgia
Being tested
Experimental: Exercise and Patient-centred education, Active Comparator: Exercise
Keywords
Fibromyalgia, Exercise, Patient-centred Education, Randomised Controlled Trial
Medical subject headings
Fibromyalgia, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Experimental: Exercise and Patient-centred educationOther

    An eight-week programme based on 24 sessions of exercise supervised by a physiotherapist. Exercise will be carried out three times a week. Once a week the exercise session is performed autonomously by patient at home (according to the physiotherapist's recommendations).

    Patient-centred Education will follow the principles of transformative learning \& incorporate patients' narratives. It will precede 9 of the 24 exercise sessions and be delivered by the same physiotherapist

  • Active Comparator: ExerciseOther

    An eight-week programme based on 24 sessions of exercise supervised by a physiotherapist. Exercise will be carried out three times a week. Once a week the exercise session is performed autonomously by patient at home (according to the physiotherapist's recommendations).

Study groups in NCT04220567
Study groupRoleWhat they receive
Exercise and Patient-centred educationExperimentalNot described
Receives: Other: Experimental: Exercise and Patient-centred education
ExerciseActive comparatorNot described
Receives: Other: Active Comparator: Exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain intensity

    Measured using the Numeric Pain Rating Scale, NPS, 0-10

    Measured: Baseline

  2. Pain intensity

    Measured using the Numeric Pain Rating Scale, NPS, 0-10

    Measured: 4 weeks

  3. Pain intensity

    Measured using the Numeric Pain Rating Scale, NPS, 0-10

    Measured: 8 weeks

  4. Pain intensity

    Measured using the Numeric Pain Rating Scale, NPS, 0-10

    Measured: Follow-up 3 months

  5. Disability and Impact of Fibromyalgia

    Measured using the Revised Fibromyalgia Impact Questionnaire, FIQr, 0-100

    Measured: Baseline

  6. Disability and Impact of Fibromyalgia

    Measured using the Revised Fibromyalgia Impact Questionnaire, FIQr, 0-100

    Measured: 4 weeks

  7. Disability and Impact of Fibromyalgia

    Measured using the Revised Fibromyalgia Impact Questionnaire, FIQr, 0-100

    Measured: 8 weeks

  8. Disability and Impact of Fibromyalgia

    Measured using the Revised Fibromyalgia Impact Questionnaire, FIQr, 0-100

    Measured: Follow-up 3 months

Secondary outcomes (8)
  1. Neuropathic components in pain

    Measured using the painDETECT Questionnaire

    Measured: Baseline

  2. Health-related Quality of Life

    Measured using the EuroQol 5D 3L, EQ 5D-3L

    Measured: Baseline

  3. Health-related Quality of Life

    Measured using the EuroQol 5D 3L, EQ 5D-3L

    Measured: 4 weeks

  4. Health-related Quality of Life

    Measured using the EuroQol 5D 3L, EQ 5D-3L

    Measured: 8 weeks

  5. Health-related Quality of Life

    Measured using the EuroQol 5D 3L, EQ 5D-3L

    Measured: Follow-up 3 months

  6. Patients' perception of improvement or decline in clinical status

    Measured using the The Patient Global Impression of Change Scale, PGIC, 1-7

    Measured: 4 weeks

  7. Patients' perception of improvement or decline in clinical status

    Measured using the Patient Global Impression of Change Scale, PGIC, 1-7

    Measured: 8 weeks

  8. Patients' perception of improvement or decline in clinical status

    Measured using the Patient Global Impression of Change Scale, PGIC, 1-7

    Measured: Follow-up 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jan 2020
  2. Study start7 Jan 2020
  3. Primary completionOct 2020 (estimated)
  4. Study completionOct 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Parallel assignment
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04220567
Sponsor's protocol ID
IPSetubalESS_SHARE
Status last verified
Mar 2020
First submitted
5 Jan 2020
Last updated
10 Mar 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Experimental: Exercise and Patient-centred education and Active Comparator: Exercise in people with Fibromyalgia, run by Instituto Politécnico de Setúbal. Escola Superior de Saúde. at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain intensity (time frame: Baseline). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in